BACKGROUND. The fragile X syndrome, the most common form of inherited mental retardation, is caused by mutations that increase the size of a specific DNA fragment of the X chromosome (in Xq27.3). Affected persons have both a full mutation and abnormal DNA methylation. Persons with a smaller increase in the size of this DNA fragment (a premutation) have little or no risk of retardation but are at high risk of having affected children or grandchildren. The passage from premutation to full-mutation status occurs only with transmission from the mother. We have devised a method of identifying carriers of these mutations by direct DNA analysis. METHOD. We studied 511 persons from 63 families with the fragile X syndrome. Mutations and abnormal methylation were detected by Southern blotting with a probe adjacent to the mutation target. Analysis of EcoRI and EagI digests of DNA distinguished clearly in a single test between the normal genotype, the premutation, and the full mutation. RESULTS. DNA analysis unambiguously established the genetic status at the fragile X locus for all samples tested. This method was much more powerful and reliable than cytogenetic testing or segregation studies with closely linked polymorphic markers. The frequency of mental retardation in persons with premutations was similar to that in the general population, whereas all 103 males and 31 of 59 females with full mutations had mental retardation. About 15 percent of those with full mutations had some cells carrying only the premutation. All the mothers of affected children were carriers of either a premutation or a full mutation. CONCLUSIONS. Direct diagnosis by DNA analysis is now an efficient and reliable primary test for the diagnosis of the fragile X syndrome after birth, as well as for prenatal diagnosis and genetic counseling.
Source Information
Institut National de la Sante et de la Recherche Medicale (INSERM), Unite 184, Strasbourg, France.
This article has been cited by other articles:
Watson, C., Hoeft, F., Garrett, A. S., Hall, S. S., Reiss, A. L.
(2008). Aberrant Brain Activation During Gaze Processing in Boys With Fragile X Syndrome. Arch Gen Psychiatry
65: 1315-1323
[Abstract][Full Text]
Cecconi, M., Forzano, F., Rinaldi, R., Cappellacci, S., Grammatico, P., Faravelli, F., Dagna Bricarelli, F., Di Maria, E., Grasso, M.
(2008). A Single Nucleotide Variant in the FMR1 CGG Repeat Results in a "Pseudodeletion" and Is Not Associated with the Fragile X Syndrome Phenotype. J. Mol. Diagn.
10: 272-275
[Abstract][Full Text]
Allen, E G, Juncos, J, Letz, R, Rusin, M, Hamilton, D, Novak, G, Shubeck, L, Tinker, S W, Sherman, S L
(2008). Detection of early FXTAS motor symptoms using the CATSYS computerised neuromotor test battery. J. Med. Genet.
45: 290-297
[Abstract][Full Text]
Cronister, A., Teicher, J., Rohlfs, E. M., Donnenfeld, A., Hallam, S.
(2008). Prevalence and Instability of Fragile X Alleles: Implications for Offering Fragile X Prenatal Diagnosis. Obstet Gynecol
111: 596-601
[Abstract][Full Text]
Turetsky, T., Aizenman, E., Gil, Y., Weinberg, N., Shufaro, Y., Revel, A., Laufer, N., Simon, A., Abeliovich, D., Reubinoff, B.E.
(2008). Laser-assisted derivation of human embryonic stem cell lines from IVF embryos after preimplantation genetic diagnosis. Hum Reprod
23: 46-53
[Abstract][Full Text]
Dahl, C., Gronskov, K., Larsen, L. A., Guldberg, P., Brondum-Nielsen, K.
(2007). A Homogeneous Assay for Analysis of FMR1 Promoter Methylation in Patients with Fragile X Syndrome. Clin. Chem.
53: 790-793
[Abstract][Full Text]
Zhou, Y., Lum, J. M.S., Yeo, G.-H., Kiing, J., Tay, S. K.H., Chong, S. S.
(2006). Simplified Molecular Diagnosis of Fragile X Syndrome by Fluorescent Methylation-Specific PCR and GeneScan Analysis. Clin. Chem.
52: 1492-1500
[Abstract][Full Text]
Saluto, A., Brussino, A., Tassone, F., Arduino, C., Cagnoli, C., Pappi, P., Hagerman, P., Migone, N., Brusco, A.
(2005). An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene. J. Mol. Diagn.
7: 605-612
[Abstract][Full Text]
O'Rahilly, S., Farooqi, I. S., Yeo, G. S. H., Challis, B. G.
(2003). Minireview: Human Obesity--Lessons from Monogenic Disorders. Endocrinology
144: 3757-3764
[Abstract][Full Text]
Gersak, K., Meden-Vrtovec, H., Peterlin, B.
(2003). Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Hum Reprod
18: 1637-1640
[Abstract][Full Text]
de Vries, B B A, Severijnen, L-A, Jacobs, A, Olmer, R, Halley, D J J, Oostra, B A, Willemsen, R
(2003). FMRP expression studies in blood and hair roots in a fragile X family with methylation mosaics. J. Med. Genet.
40: 535-539
[Full Text]
Longo, I, Frints, S G M, Fryns, J-P, Meloni, I, Pescucci, C, Ariani, F, Borghgraef, M, Raynaud, M, Marynen, P, Schwartz, C, Renieri, A, Froyen, G
(2003). A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients. J. Med. Genet.
40: 11-17
[Abstract][Full Text]
Valleix, S., Vinciguerra, C., Lavergne, J.-M., Leuer, M., Delpech, M., Negrier, C.
(2002). Skewed X-chromosome inactivation in monochorionic diamniotic twin sisters results in severe and mild hemophilia A. Blood
100: 3034-3036
[Abstract][Full Text]
Tarleton, J, Kenneson, A, Taylor, A K, Crandall, K, Fletcher, R, Casey, R, Hart, P S, Hatton, D, Fisch, G, Warren, S T
(2002). A single base alteration in the CGG repeat region of FMR1: possible effects on gene expression and phenotype. J. Med. Genet.
39: 196-200
[Full Text]
Dombrowski, C., Levesque, S., Morel, M. L., Rouillard, P., Morgan, K., Rousseau, F.
(2002). Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet
11: 371-378
[Abstract][Full Text]
Bontekoe, C. J. M., Bakker, C. E., Nieuwenhuizen, I. M., van der Linde, H., Lans, H., de Lange, D., Hirst, M. C., Oostra, B. A.
(2001). Instability of a (CGG)98 repeat in the Fmr1 promoter. Hum Mol Genet
10: 1693-1699
[Abstract][Full Text]
Eliez, S., Blasey, C. M., Freund, L. S., Hastie, T., Reiss, A. L.
(2001). Brain anatomy, gender and IQ in children and adolescents with fragile X syndrome. Brain
124: 1610-1618
[Abstract][Full Text]
Kenneson, A., Zhang, F., Hagedorn, C. H., Warren, S. T.
(2001). Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet
10: 1449-1454
[Abstract][Full Text]
Salat, U., Bardoni, B., Wöhrle, D., Steinbach, P.
(2000). Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?. J. Med. Genet.
37: 842-850
[Abstract][Full Text]
Daly, T. M., Rafii, A., Martin, R. A., Zehnbauer, B. A.
(2000). Novel Polymorphism in the FMR1 Gene Resulting in a "Pseudodeletion" of FMR1 in a Commonly Used Fragile X Assay. J. Mol. Diagn.
2: 128-131
[Abstract][Full Text]
Youings, S. A, Murray, A., Dennis, N., Ennis, S., Lewis, C., McKechnie, N., Pound, M., Sharrock, A., Jacobs, P.
(2000). FRAXA and FRAXE: the results of a five year survey. J. Med. Genet.
37: 415-421
[Abstract][Full Text]
Marozzi, A., Vegetti, W., Manfredini, E., Tibiletti, M. G., Testa, G., Crosignani, P. G., Ginelli, E., Meneveri, R., Dalpra, L.
(2000). Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod
15: 197-202
[Abstract][Full Text]
Hmadcha, A., Bedoya, F. J., Sobrino, F., Pintado, E.
(1999). Methylation-dependent Gene Silencing Induced by Interleukin 1{beta} Via Nitric Oxide Production. JEM
190: 1595-1604
[Abstract][Full Text]
Marozzi, A., Dalpra, L., Ginelli, E., Tibiletti, M. G., Crosignani, P. G., Conway, G. S.
(1999). FRAXA premutations are not a cause of familial premature ovarian failure. Hum Reprod
14: 573-575
[Full Text]
de Vries, B. B A, van den Boer-van den Berg, H. M A, Niermeijer, M. F, Tibben, A.
(1999). Dilemmas in counselling females with the fragile X syndrome. J. Med. Genet.
36: 167-170
[Abstract][Full Text]
Slegtenhorst-Eegdeman, K. E., de Rooij, D. G., Verhoef-Post, M., van de Kant, H. J. G., Bakker, C. E., Oostra, B. A., Grootegoed, J. A., Themmen, A. P. N.
(1998). Macroorchidism in FMR1 Knockout Mice Is Caused by Increased Sertoli Cell Proliferation during Testicular Development. Endocrinology
139: 156-162
[Abstract][Full Text]
Sotos, J. F.
(1997). Section IV Genetic Disorders Associated with Overgrowth. CLIN PEDIATR
36: 39-49
Eberhart, D.E., Warren, S.T.
(1996). The Molecular Basis of Fragile X Syndrome. Cold Spring Harb Symp Quant Biol
61: 679-687
[Abstract]
Feng, Y, Zhang, F, Lokey, L., Chastain, J., Lakkis, L, Eberhart, D, Warren, S.
(1995). Translational suppression by trinucleotide repeat expansion at FMR1. Science
268: 731-734
[Abstract]
Nancarrow, J., Kremer, E, Holman, K, Eyre, H, Doggett, N., Le Paslier, D, Callen, D., Sutherland, G., Richards, R.
(1994). Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science
264: 1938-1941
[Abstract]
Brunner, H. G., Jansen, G., Nillesen, W., Nelen, M. R., de Die, C., Howeler, C. J., van Oost, B. A., Wieringa, B., Ropers, H.-H., Smeets, H.
(1993). Reverse Mutation in Myotonic Dystrophy. NEJM
328: 476-480
[Full Text]
Mandel, J., Monaco, A., Nelson, D., Schlessinger, D, Willard, H
(1992). Genome analysis and the human X chromosome. Science
258: 103-109
[Abstract]
